Conclusion: A decision aid improved the quality of clinical decisions about bisphosphonate therapy in at-risk postmenopausal women, did not affect start rates, and may have improved adherence. (Source: The American Journal of Medicine)
View the Full Blog Here
Asbestos Compensation Claim Blog Here
Decision,Improve,Treatment,Decisions,Osteoporosis,Osteoporosis,Choice,Randomized,Trial
No comments:
Post a Comment